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Introduction: Overweight status should not be considered merely an aesthetic concern; rather, it can incur health
risks since it may trigger a cascade of events that produce further fat tissue through altered levels of circulating
signaling molecules.
There have been few studies addressing the effect of overweight status on the physiological functions of stem
cells, including mesenchymal stem cells (MSCs), which are the progenitors of adipocytes and osteocytes and are a
subset of the bone marrow stromal cell population.
Methods: We decided to investigate the influence of overweight individuals’ sera on in vitro MSC proliferation and
differentiation.
Results: We observed that in vitro incubation of bone marrow stromal cells with the sera of overweight individuals
promotes the adipogenic differentiation of MSCs while partially impairing proper osteogenesis.
Conclusions: These results, which represent a pilot study, might suggest that becoming overweight triggers further
weight gains by promoting a bias in the differentiation potential of MSCs toward adipogenesis. The circulating factors
involved in this phenomenon remain to be determined, since the great majority of the well known pro-inflammatory
cytokines and adipocyte-secreted factors we investigated did not show relevant modifications in overweight serum
samples compared with controls.Introduction
Overweight status and obesity refer to total body weights
greater than those considered healthy [1]. Although the
public health and medical consequences of the rise in
obesity are evident, overweight status is only considered
critical for body image and the damaging consequences
in terms of health and well-being are often considered
negligible in the eyes of the general public as well as
specific populations (for example, healthcare profes-
sionals) [2]. Nevertheless, several studies have suggested
an association between overweight status and human* Correspondence: umberto.galderisi@unina2.it
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article, unless otherwise stated.pathologies, such as coronary hearth diseases and chronic
kidney disease [3,4].
Studies on the association between overweight status
and disease are mainly correlative, and no insights on
the biological bases are given. It is evident that in over-
weight and obese people the level of several circulating
cytokines, hormones and other signaling molecules may
be dysregulated [4]. This may affect the functions of se-
veral organs and tissues, including the stem cell niches,
which are subsets of tissues and extracellular subsets
that can indefinitely house stem cells and control their
self-renewal and progeny production by modulating the
concentration of signaling molecules, such as hormones,
cytokines, growth factors and so on. [5].
There have been few studies of the effects of over-
weight status on the physiological functions of stem
cells, including those present in bone marrow (BM). The
microenvironment of mammalian BM is composed ofntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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and bone homeostasis [6]. It includes a heterogeneous
population of cells: macrophages, fibroblasts, adipocytes,
osteoprogenitors, endothelial cells and reticular cells.
Among these, there are several types of stem cells:
hematopoietic stem cells (HSCs), endothelial progenitor
cells (EPCs), and mesenchymal stem cells (MSCs), which
are a subset of the marrow stromal cell population. MSCs
differentiate into mesenchymal tissues, such as bone, car-
tilage and fat cells, but also support hematopoiesis and
contribute to the homeostatic maintenance of many or-
gans and tissues and, therefore, also offer significant thera-
peutic potential for tissue regeneration. As a result of the
multiple roles that MSCs play in the physiology of an or-
ganism, impairment of their functions can have profound
consequences for body physiology [7-9].
Adipocytes and osteocytes arise from MSCs. Their des-
tinies are not mutually exclusive, but rather are inter-
twined, as they share a variety of genetic, hormonal and
environmental factors. The available literature indicates
that obesity may decrease osteoblastogenesis while in-
creasing adipogenesis. It remains to be determined how
obesity may affect these processes [10]. Some clues may
be derived by considering that the traditional view of adi-
pose tissue as a passive reservoir for energy storage is no
longer valid. Indeed, the physiology and role of adipose
tissue is more complex than previously thought. Besides
the white adipose tissue (WAT), which is the most abun-
dant human fat, there are two other adipose tissue types
that differ significantly from WAT. Brown adipose tissue
(BAT), the main role of which is the regulation of thermo-
genesis through burning of energy rather than its storage
is the second type. Bone marrow adipose tissue (BMAT) is
the third fat depot and has similarities to both WAT and
BAT. Fat occupies a significant portion of the bone cavity;
however, its role is largely unknown. The BMAT was trad-
itionally thought to have no function and has been over-
looked or ignored for a long time [11]. Several studies
have shown that cells in the bone marrow niche commu-
nicate with each other and are essential for the maturation
and correct functioning of MSCs and HSCs. Adipocytes in
bone marrow may cooperate with resident stem cells by
acting as placeholders until the stem cells differentiate
into the cell type that is needed. BMAT may also play a
role in energy storage and thermogenesis and impaired
functions of BMAT may influence bone remodeling
through the secretion of cytokines that target bone, the
production of signaling molecules that affect sympathetic
impulses to bone and also through the paracrine influ-
ences on adjacent skeletal cells [12].
In overweight and obese people, the dysregulated level
of circulating signaling factors may also affect the diffe-
rentiation potential of bone marrow resident MSCs,
altering the equilibrium between adipo- and osteogenesis.We decided to investigate this phenomenon by analyzing
the influence of sera from overweight individuals on
in vitro MSC proliferation and differentiation.
Methods
Ethical approval
The experimental procedures followed the rules ap-
proved by the Ethics Committee of the Second University
of Naples. In detail, patients were informed of the re-
search and gave permission for the use of serum samples
and/or bone marrow harvests.
Serum samples
Serum samples were collected from five adult men of
healthy weight (body mass index (BMI) <25) and eight adult
men with BMIs >25 (overweight), after informed consent.
Whole blood samples (10 ml) were collected from patients
in Vacutainer test tubes (BD Bioscience, Buccinasco, Italy).
After collection, the samples were left undisturbed to allow
the blood to clot at room temperature. The clots were re-
moved by centrifuging at 1,000 to 2,000 g for 10 minutes in
a refrigerated centrifuge. The resultant supernatants were
designated sera and were collected with a Pasteur pipette.
We pooled sera from the healthy weight and overweight
samples to create two different experimental groups: ‘healthy
weight’ (HS) and ‘overweight’ sera (OS), respectively.
Bone marrow stromal cell cultures
Bone marrow was obtained from three healthy donors.
We used bone marrow from a 10-year-old, 12-year-old
and 13-year-old male donor, after their parents gave in-
formed consent. We separated cells using a Ficoll density
gradient (GE Healthcare, Milan, Italy), and the mono-
nuclear cell fraction was collected and washed in PBS. We
seeded 1 to 2.5 × 105 cells/cm2 in alpha-minimum essen-
tial medium (alpha-MEM) containing 10% fetal bovine
serum (FBS) and 1 ng/ml beta-fibroblast growth factor
(β-FGF). After 72 hours, non-adherent cells were dis-
carded, and adherent cells were further cultivated to con-
fluency. Cells were then incubated for seven to ten days in
proliferating medium to reach confluence and extensively
propagated for our experimental plan. We verified that,
under our experimental conditions, the bone marrow
stromal cultures contained MSCs that fulfilled the three
criteria proposed to define MSCs [13]. All experiments
were carried out on MSC cultures at passage 3.
For evaluation of the effects of OS and HS on in vitro
MSC functions, cells were incubated for 72 hours in
alpha-MEM containing 10% human serum pools and
1 ng/ml β-FGF. At the end of that time, samples were
collected for analysis.
All cell culture reagents were obtained from Euroclone
Life Sciences (Milan, Italy) and Hyclone (UT, Logan,
USA) unless otherwise stated.
Table 1 Main blood serum biochemical indicators
Patient parameters Healthy weight Overweight
BMI (Kg/m2) 21.10 ±1.10 29.63 ± 1.80*
Glucose (mmol/l) 88.8 ± 5.22 90.63 ± 8.94
Total cholesterol (mmol/l) 205.6 ± 26.18 203.5 ± 42.37
LDL cholesterol (mmol/l) 124.8 ± 24.10 131.6 ± 41.27
HDL cholesterol (mmol/l) 65.6 ± 15.14 56.4 ± 8.52
Triglycerides (mmol/l) 77.2 ± 30.43 100.1 ± 46.42
Patients were divided into two groups of healthy weight (n = 5) and
overweight (n = 8) individuals, that showed significant differences (P <0.05) in
BMI. Other parameters did not present statistically significant differences and
were in the normal value range for both groups. Data are expressed as mean
values with standard deviations (*P <0.05). BMI, body mass index; HDL, high
density lipoprotein; LDL, low density lipoprotein.
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Apoptotic cells were detected through the use of fluorescein-
conjugated Annexin V (Roche, Milan, Italy) following
the manufacturer’s instructions. Apoptotic cells were
observed through a fluorescence microscope (Leica
Italia, Milan, Italy). In every experiment, at least 1,000
cells were counted in different fields to calculate the
percentage of dead cells in each culture.
Senescence-associated β-galactosidase assay
Cells were fixed for 10 minutes with a solution of
2% (v/v) formaldehyde and 0.2% (w/v) glutaraldehyde.
Cells were washed with PBS and then incubated at
37°C for at least two hours with a staining solution
(30 mM citric acid/phosphate buffer (pH 6), 5 mM
K4Fe(CN)6, 5 mM K3Fe(CN)6, 150 mM NaCl, 2 mM
MgCl2, 1 mg/ml 5-bromo-4-chloro-3-indolyl-beta-D-
galacto-pyranoside (X-Gal) solution). The percentage of
senescent cells was calculated by the number of blue
cells (β-galactosidase positive cells) out of at least 500
cells in different microscope fields.
Adipogenic differentiation
Bone marrow stromal cultures were incubated for 72
hours in alpha-MEM containing 10% of each serum
pool (HS or OS) and β-FGF. Then the cells were stimu-
lated for 15 days in hMSC mesenchymal stem cell
adipogenic differentiation medium (catalog n. PT-3004-
KT - Lonza, Walkersville, MD, USA). The medium con-
tains insulin (recombinant), dexamethasone, indometh-
acin and 3-isobuty-l-methyl-xanthine (IBMX). Lipid
droplets were revealed by staining with Oil Red O. Adi-
pogenic differentiation was evaluated by determining
the expression of genes involved in adipogenesis, such as
C/EBPß and C/EBP∂ (early genes) and PPARγ, C/EBPα,
LPL and ATGL (late genes).
Osteogenic differentiation
After 72 hours of serum treatment, HS or OS cells were
stimulated for 15 days in hMSC mesenchymal stem cell
osteogenic differentiation medium (catalog n. PT-3002-
KT-Lonza). The medium contains dexamethasone, as-
corbate and glycerophosphate. Staining with Alizarin red
revealed calcium deposits in differentiated osteocytes.
Osteogenic differentiation was evaluated by determining
the expression levels of osteopontin and osterix, both
involved in osteogenesis.
Reactive oxygen species detection
For each serum group (HS or OS), intracellular reactive
oxygen species (ROS) levels were investigated using
the d-ROMs test (Diacon, Grosseto, Italy) according to
the manufacturer’s instructions. ROMs (hydropero-
xides, ROOH, primarily) in a biological sample in thepresence of iron (released from plasma proteins by an
acidic buffer, the R2 reagent in the kit) are able to ge-
nerate alkoxyl (R-O*) and peroxyl (R-OO*) radicals,
through the Fenton reaction. Such radicals, in turn,
are able to oxidize an alkyl-substituted aromatic amine
(A-NH2, solubilized in a chromogenic mixture, the R1
reagent of the kit), thus transforming them into a pink-
colored derivative ((A-NH2*)+). Finally, this colored
derivative is photometrically quantified by measuring
absorbance (at 505 nm or 546 nm) (Tecan, Mannedorf,
Switzerland). The intensity of the developed color is
directly proportional to the concentration of ROMs,
according to Lambert-Beer’s law.
Cytokine array
The profile of the relative levels of 18 cytokines in
the serum samples harvested from the healthy weight
and overweight groups was determined using the Human
Cytokine Antibody Array 1.0 (Affymetrix, Emeryville, CA,
USA). The nitrocellulose membranes provided by the
manufacturer contain 18 capture antibodies spotted in du-
plicate on the surface. Each membrane also included four
pairs of positive control spots and two pairs of negative
control spots. A total of 2 ml of the serum samples for
each of the two experimental groups was used for
hybridization. Hybridizations and signal measurements
were done following the manufacturer’s instructions.
Array signals were acquired using the Chemidoc system
(Bio-Rad Company, Hercules, CA, USA) and the associ-
ated software QuantityOne. Array images used for signal
quantification (expressed as pixel density) were produced
through five minute camera exposures. All the mem-
branes were processed simultaneously. All hybridizations
were repeated twice.
RNA extraction and RT-PCR
Total RNA was extracted from the cell cultures using TRI
REAGENT (Molecular Research Center Inc., Cincinnati, OH,
USA) according to the manufacturer’s protocol. The mRNA
Figure 1 Experimental plan. Bone marrow was collected from healthy patients and mononuclear cell fractions were used to provide bone
marrow stromal cultures containing MSCs. Cultures were propagated for seven to ten days. Then cultures were treated with OS and HS for three
days (priming). At the end of priming, apopotosis and senescence were evaluated. Cultures were then incubated in adipogenic or osteogenic
differentiation media for 15 days and the differentiation processes were evaluated. HS, healthy weight sera; MSCs, mesenchymal stem cells;
OS, overweight sera.
Figure 2 Senescence and apoptosis assays. Acid β-galactosidase
and Annexin V assays were carried out to detect senescent and
apoptotic cells in MSC samples treated with HS and OS. The picture
shows representative fields of acid β-galactosidase (left) and Annexin
staining (right). Arrowheads indicate senescent cells. Annexin-positive
cells are green. Cells were counterstained with DAPI (blue). Mean
expression values for senescent and apoptotic cells are indicated in the
corresponding table (± SD, number of experiment replicates: three).
DAPI, 4',6-diamidino-2-phenylindole; HS, healthy weight sera; MSCs,
mesenchymal stem cells; OS, overweight sera.
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lification, as previously reported [14,15].
Sequences for mRNAs from the nucleotide data bank
(National Center for Biotechnology Information, Bethesda,
MD, USA) were used to design primer pairs for RT-PCR reac-
tions (Primer Express, Applied Biosystems, Carlsbad, CA,
USA). Primer sequences are in Additional file 1. Appropriate
regions of GAPDH cDNA were used as controls. PCR cycles
were adjusted to have linear amplification for all the targets.
Each RT-PCR reaction was repeated at least three times. A
semi-quantitative analysis of mRNA levels was carried out
using the ‘GEL DOC UV SYSTEM (Bio-Rad). Primer
sequences were designed with Primer Express software
(Invitrogen, Milan, Italy).
Statistical analysis
Statistical significance was evaluated using analysis of vari-
ance (ANOVA) followed by Student’s t and Bonferroni’s
tests. In analyzing the data with randomized group design,
the variances within and between the groups need to be
counted. We used mixed-model variance analysis for data
with continuous outcomes. All data were analyzed with
GraphPad Prism-version 5.01 statistical software package
(GraphPad, La Jolla, CA, USA).
Results
We divided our sample into two groups: HS (n = 5) and
OS (n = 8). We did not observe significant intra- or
inter-group differences in the levels of the main blood
serum biochemical indicators (Table 1 and Additional
file 2). For this reason, we adopted a pooling strategy to
compensate for the limited numbers of samples and to
reduce biological variation [16]. The overall research
strategy is depicted in Figure 1.Overweight sera did not affect the proliferation,
apoptosis or senescence rate of MSC cultures
We evaluated whether some in vitro biological properties
of MSCs were affected differently by incubation with OS
compared with cells treated with HS. Proliferation rates of
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those treated with HS [see Additional file 3]. Changes in
the circulating cytokines and hormones of overweight
people may affect the cell biology of MSCs and drive cells
to different possible fates, including apoptosis and senes-
cence. These outcomes are not mutually exclusive, despite
the fact that some cellular stresses preferentially induce
one or the other of these two fates [17].
The Annexin assay did not show a significant diffe-
rence in the percentage of apoptotic cells in cultures
treated with OS as compared to the controls (Figure 2).
The senescence process was also unaffected by OS
treatment, as detected by the acid beta-galactosidase
assay (Figure 2).
Adipogenic differentiation
Fat accumulation is closely related to bone formation and
resorption, and it has been suggested that obesity may de-
crease bone formation while increasing adipogenesis [10].Figure 3 Analysis of adipocyte differentiation. A) The table shows the
induced to differentiate into adipocytes. The percentage of Oil Red O posit
microscope fields. Data are expressed as mean values with standard deviat
positive cells. B) RT-PCR expression analysis of early and late adipocyte diffe
to differentiate into adipocytes. mRNA levels were normalized with respect
was repeated at least three times. The histogram shows the changes in mR
conditions of MSCs grown in OS (red bars) or HS (black bars). They are exp
mesenchymal stem cells; OS, overweight sera.For this reason, we looked at the effects of OS on MSC
differentiation into adipocytes. MSC cultures were incu-
bated for 72 hours in alpha-MEM containing 10% of
OS or HS. The cells were then stimulated for 15 days
in mesenchymal stem cell adipogenic differentiation
medium (Lonza). OS treatment induced a higher per-
centage of differentiated adipocytes (64 ± 6%) compared
with HS (40 ± 4%), as determined by Oil Red O staining
(Figure 3A). These data were confirmed by expression
analysis of early (C/EBPß and C/EBPδ) and late (PPARγ,
C/EBPα, LPL, and ATGL) adipocyte differentiation
markers. In proliferating MSCs we detected only a
minimal amount of C/EBPß and C/EBPδ both in cells
grown with HS and with OS; there were no significant
differences between the two experimental conditions.
Following incubation in differentiation medium, we ob-
served a higher increase in the expression of adipogenic
markers in OS treated cultures, compared with cells
incubated with HS (Figure 3B).percentage of Oil Red O positive cells treated with OS or HS and then
ive cells was calculated by counting at least 500 cells in different
ions (*P <0.05). The picture shows a representative field of oil-red
rentiation markers in MSCs treated with OS or HS and then induced
to GAPDH, which was chosen as an internal control. Each experiment
NA expression levels 14 days after incubation in differentiation
ressed as arbitrary units (*P <0.05). HS, healthy weight sera; MSCs,
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differentiation
We examined the effects of OS on MSC differentiation
into osteocytes in a similar fashion (Figure 4A, B, C, D).
Alizarin red staining did not show considerable diffe-
rences in the osteogenesis process of MSCs incubated
with OS or HS (Figure 4D). To gain further insights into
osteocyte differentiation, we performed a follow up ex-
pression analysis of osteopontin and osterix, which are
involved in the osteocyte differentiation process [18,19].
In HS-treated MSCs, the differentiation marker osterix
showed a typical bimodal expression profile, with a
burst in expression during the first stage of differenti-
ation (Figure 4C). This expression pattern was altered in
the OS-treated MSCs. The osteopontin expression pro-
file was also altered in OS-treated cells compared with
HS samples. As expected, in HS-treated MSCs, the ex-
pression level of osteopontin, an early differentiation
marker, was high in the first days of differentiation, then
declined and remained stable during the entire maturation
process (Figure 4B). On the contrary, in OS-treated MSCs,
osteopontin expression, after an initial decrease, exhi-
bited a progressive increase in mRNA levels during theFigure 4 Analysis of osteocyte differentiation. A) The picture shows a r
differentiation of MSCs. Image taken on an upright inverted microscope wi
osteopontin (B) and osterix (C) during osteocyte differentiation of MSCs tre
GAPDH, which was chosen as an internal control. Each experiment was rep
levels. They are expressed as arbitrary units (*P <0.05). D) The picture show
induced to differentiate into osteocytes. Control: cells not induced to differ
acquired with a CCD camera and analyzed with Quantity One 1-D analysis
values of stained cells and then determined the average fluorescent pixel i
overweight sera.late differentiation phase (Figure 4B). This result sug-
gests that osteocyte differentiation may be dysregulated
in OS samples.
Comparison of cytokine expression profiles in overweight
and healthy weight sera
Adipose tissue secretes a variety of products known as
adipokines, including leptin, adiponectin, resistin, and
visfatin, as well as cytokines and chemokines such as
TNF-α, IL-6, and monocyte chemoattractant protein-1
(MCP-1). The release of adipokines by either adipocytes
or adipose tissue-infiltrated macrophages leads to low-
grade inflammation, a hallmark characterizing adult
obesity, which may be a pivotal mechanism linking obe-
sity to its numerous systemic complications [20].
We used the Panomics TranSignal Human Cytokine
Antibody Array (Affymetrix) to accurately profile the ex-
pression of 18 of the most studied cytokines. The expres-
sion levels of several cytokines did not differ significantly
between the OS and HS samples. Several cytokines were
easily detectable on the arrays but their low levels did not
allow a quantitative comparison (Figure 5A). Notably,
levels of leptin, whose synthesis and secretion is increasedepresentative image of an osteon formation following osteocyte
th a 20× objective. The graph represents the expression follow up of
ated with OS or HS. mRNA levels were normalized with respect to
eated at least three times. The histogram shows the mRNA expression
s Alizarin red staining of MSCs treated with OS or HS and then
entiate. The Alizarin red staining intensity for each cell culture dish was
software (Bio-Rad). We calculated the sum of the fluorescent pixel
ntensity. HS, healthy weight sera; MSCs, mesenchymal stem cells; OS,
Figure 5 Cytokine and reactive oxygen species (ROS) detection in sera. A) Arrays incubated with HS and OS samples. The table below
the arrays shows the name and the relative position on the Panomics TranSignal Human Cytokine Antibody Array of the cytokines that were
detected in OS and HS sera. On the table ‘Positive’ and ‘Negative’ are the array internal controls. Array signals were acquired using the Chemidoc
system (Bio-Rad) and the associated software QuantityOne. The graph shows the cytokine expression levels in the OS and HS sera. Data are
expressed as arbitrary units (*P < 0.05). B) The table shows the expression of ROS in HS and OS samples. Data are expressed in arbitrary units
(± SD, number of experiment replicates: three). HS, healthy weight sera; OS, overweight sera.
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did not differ significantly in overweight samples com-
pared with controls (Figure 5A) [21].
Several findings support a direct correlation between
the levels of inflammatory cytokines (IL-1β, IL-6, TNF-α)
and BMI [22,23]. Unexpectedly, TNF-α and IL-1β levels
were lower in the OS than the HS, while no significant
modification of IL-6 was detected (Figure 5A) [24]. In OS
we also observed a decrease in the expression of the anti-
inflammatory cytokine IL-10 (Figure 5A).
Fat accumulation is correlated with systemic oxidative
stress in humans and mice. Production of ROS increases
selectively in the adipose tissue of obese mice, accom-
panied by augmented expression of NADPH oxidase and
decreased expression of antioxidative enzymes [25]. We
decided to investigate if an increased level of ROS in OS
may account for its effect on adipogenesis, since there
are reports showing that increases in intracellular ROSlevels mediate the adipocytic differentiation of MSCs
[26]. The ROS levels in sera from OS and HS samples
did not differ significantly as detected by the d-ROMs
test (Diacon) (Figure 5B).
Discussion
The great majority of studies on obesity focus on the ana-
lysis of wholly obese individuals (BMI >30). Nevertheless,
it is becoming clear that overweight status should be
considered not merely an aesthetic concern, but rather
can also be related to health risks. In addition, over-
weight status may trigger a cascade of events, increas-
ing fat tissue through alterations in levels of circulating
signaling molecules. We decided to investigate the ef-
fect of sera from overweight individuals on the differen-
tiation potential of MSCs, which are precursors of
adipocytes and osteocytes. This represents a pilot study
due to the small number of cases evaluated. For this
Di Bernardo et al. Stem Cell Research & Therapy 2014, 5:4 Page 8 of 9
http://stemcellres.com/content/5/1/4reason, the conclusions based on this finding must be
confirmed with further analytical studies employing the
sera of a larger number of subjects.
Several reports support the existence of a homeostatic
system that dynamically adjusts energy intake and energy
expenditure to promote body fat mass stability. In the
context of this system, the ease with which many
individuals gain weight is difficult to explain. Our data
may offer a hint about the mechanism underlying these
observations. We observed that in vitro incubation of
MSCs with the sera of overweight individuals promotes
adipocytic differentiation of MSCs, while partially impair-
ing proper osteocyte differentiation (Figures 3 and 4).
These results may suggest that becoming overweight
triggers a further gain of weight by promoting a bias in
the differentiation potential of MSCs toward adipoge-
nesis. This may occur through a modification in the ex-
pression pattern of circulating cytokines, hormones,
and growth factors. This hypothesis is in agreement with
the theory that energy homeostasis operates primarily to
defend against weight loss and that, over the course of
evolution, biological defense against weight gain was not
selected for [27].
The circulating factors involved in this phenomenon
remain to be determined, since the great majority of the
well-known pro-inflammatory cytokines and adipocyte-
secreted factors we investigated did not show relevant
modifications in OS samples compared with controls.
It now appears that in most obese patients obesity is
associated with a low-grade inflammation, resulting from
chronic activation of the innate immune system and an
increase in circulating pro-inflammatory cytokines [28].
Indeed, several studies have demonstrated a direct cor-
relation between the levels of inflammatory cytokines
(IL-1β, IL-6, TNF-α) and BMI. Nevertheless, our data
conflict with these previously published data, in that
serum IL-6 levels were similar between overweight and
control groups, and TNF-α and IL-1β levels were lower
in overweight subjects, although others have shown no
elevation of serum IL-6 or TNF-α in obese patients
[24,29,30].
There are some potential explanations for these dis-
cordant data. The main hypothesis is that our analysis
was carried out on overweight individuals, so alterations
in circulating cytokines may not be strictly comparable
with those of obese subjects. It should be emphasized
that in overweight samples we detected a decrease of
IL-10, an anti-inflammation cytokine. This may suggest
that in overweight individuals the pro-inflammation
status may be sustained by changes in cytokine expres-
sion that do not completely overlap with those observed
in obese subjects.
Larger studies in which patients are better matched for
the potential clinical variables that might impact serumcytokine levels would define precise alterations in serum
cytokine levels in different subsets of obese patients.
Further investigation could take into account the ob-
servation that inflammation-sensitive plasma proteins
(ISPs) (fibrinogen, orosomucoid, α1-antitrypsin, hapto-
globin, and ceruloplasmin) are associated with future
weight gain [31].
Conclusion
In conclusion, our study reinforces the idea that over-
weight status should not be considered a mere aesthetic
concern, but rather should be adequately addressed to
avoid triggering obesity and related diseases.
Additional files
Additional file 1: Parameters for RT-PCR analysis.
Additional file 2: Demographic data of enrolled patients.
Additional file 3: Effect of HS, OS and fetal bovine (FBS) sera on
cell growth. Cell proliferation was evaluated by a Quick Cell Proliferation
Assay Kit II (Biovision). Cells were seeded in 96-well culture plates. At 1, 2,
5, 10 and 15 days post-plating, cells were collected and counted. The
ratio of the total number of cells at day ‘n’ to the number of cells at day
‘n – 1’ was regarded as the cell proliferation rate.
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